Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Witnesses cite insurance-claims analysis in support of Patient Protection Act; committee seeks peer-reviewed data
Summary
Supporters of HB324 told the House Health Committee the Patient Protection Act would require in-person exams and stricter dispensing for drugs tied to severe adverse events; a witness cited an insurance-claims analysis alleging higher-than-reported complications from mifepristone, prompting members to request the study's methodology and peer review.
The House Health Committee heard proponent testimony on House Bill 324, the Patient Protection Act, which sponsors say would require in-person care and additional safeguards for medications associated with serious adverse events.
Marsha Forsen of the Catholic Conference of Ohio testified that the measure "employs reasonable safeguards on the dispensing of medications known to cause serious adverse effects by prohibiting the sale of such drugs without a prescription and requiring that patients be…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
